Resumen de acción STAR
Strides Pharma Science Limited desarrolla, fabrica y vende productos farmacéuticos en África, Australia, Norteamérica, Europa, Asia, India y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Competidores de Strides Pharma Science Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹896.80 |
| 52 Week High | ₹911.75 |
| 52 Week Low | ₹338.90 |
| Beta | 0.78 |
| 1 Month Change | 8.43% |
| 3 Month Change | 28.15% |
| 1 Year Change | 151.45% |
| 3 Year Change | 5.13% |
| 5 Year Change | 85.12% |
| Change since IPO | 0.13% |
Noticias y actualizaciones recientes
Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)
Apr 04
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Feb 29Recent updates
Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)
Apr 04Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Feb 29Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story
Dec 23We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt
Sep 26Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Jun 08Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
Aug 02Is Strides Pharma Science (NSE:STAR) A Risky Investment?
Jun 25Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Dec 21Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50
Jul 28Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)
Apr 13Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?
Mar 04These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively
Feb 15Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?
Jan 26The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It
Jan 11
Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?
Dec 28Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?
Nov 25Insider Buying: The Strides Pharma Science Limited (NSE:STAR) Non-Executive Director Just Bought 52% More Shares
Aug 17What You Can Learn From Strides Pharma Science Limited's (NSE:STAR) P/E
Aug 11Rentabilidad de los accionistas
| STAR | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 1.5% | 1.4% | 1.2% |
| 1Y | 151.5% | 57.1% | 45.3% |
Rentabilidad vs. Industria: STAR superó al sector Indian Pharmaceuticals , que obtuvo un rendimiento del 56.7% el año pasado.
Rentabilidad vs. Mercado: STAR superó al mercado Indian, que obtuvo un rendimiento del 46.1% el año pasado.
Volatilidad de los precios
| STAR volatility | |
|---|---|
| STAR Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: El precio de las acciones de STAR ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de STAR (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1990 | 2,850 | Arun Pillai | www.strides.com |
Strides Pharma Science Limited desarrolla, fabrica y vende productos farmacéuticos en África, Australia, Norteamérica, Europa, Asia, India y a escala internacional. Opera a través de dos segmentos, el farmacéutico y el biofarmacéutico. La empresa ofrece genéricos farmacéuticos en diversas formas, como comprimidos, cápsulas de gelatina dura y blanda, sobres y líquidos, así como aerosoles nasales, polvos, sólidos, pomadas y cremas.
Resumen de fundamentos de Strides Pharma Science Limited
| Estadísticas fundamentales de STAR | |
|---|---|
| Capitalización bursátil | ₹82.42b |
| Beneficios(TTM) | -₹1.52b |
| Ingresos (TTM) | ₹39.53b |
2.1x
Ratio precio-ventas (PS)-54.1x
Ratio precio-beneficio (PE)¿Está STAR sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de STAR | |
|---|---|
| Ingresos | ₹39.53b |
| Coste de los ingresos | ₹17.56b |
| Beneficio bruto | ₹21.97b |
| Otros gastos | ₹23.50b |
| Beneficios | -₹1.52b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -16.59 |
| Margen bruto | 55.58% |
| Margen de beneficio neto | -3.86% |
| Ratio deuda/patrimonio | 140.2% |
¿Cómo se ha desempeñado STAR a largo plazo?
Ver rendimiento histórico y comparativa